Concerns growing over another price cuts in blockbuster drugs

The government’s plan to re-price the drugs that exceed their initial sales forecasts in the first half of next year has triggered concerns from the industry.

Under the current regulation, drug manufacturers and the National Health Insurance Corporation (NHIC) will be called to discuss the volume forecasts for a drug when it is first added to the reimbursement list. After one year, stakehold...